The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Distant corrected intermediate visual acuity
Timeframe: 2-6 months
Best-corrected distance visual acuity (BCDVA) - Acrysof IQ Vivity IOL, IC-8 Apthera IOL
Timeframe: 3-5 months
Contrast sensitivity and reading ability - Vivinex XC1 and Vivinex XY1
Timeframe: 2-6 months and 1-5 years
Christina Leydolt, MD